You are here:   About Us
  |  Login


  Michelle Avramidis is the Director of Skintography and has been involved in scientific research since graduating from BSc at the University of Sydney in 1996. For ten years she worked at the Sydney Melanoma Unit at the Royal Prince Alfred Hospital, Sydney. This unit has the largest database of melanoma patients in the world. 

She has trained and worked with the world’s leading melanoma experts – Professor Scott Menzies, the now retired Emeritus Professor William McCarthy and Professor John Thompson.

She has a special interest in Total Body Photography and digital skin monitoring and to date has photographed over 5,000 patients equating to over 20,000 lesions. 

Michelle uses Dermoscopix with ongoing success and results at clinics throughout Sydney.

She currently is cited in over 10 publications on the subject of skin cancer.

Michelle's experience and expertise led her to develop Dermoscopix, a brand new software program specifically developed for melanoma tracking by medical professionals.

Michelle's special interest in skin imaging and melanoma surveillance photography led her to explore a new way to track lesions and melanoma.  

Dermoscopix makes skin cancer tracking easy for all medical professionals.

Michelle's Publications:

1. Altamura D, Menzies SW, Argenziano G, Avramidis M et al. Dermatoscopy of basal cell carcinoma: Morphologic variability of global and local features and accuracy of diagnosis. JAAD 2010 Jan; 62: 67-75. 

2. Guitera P, Pellacani G, Longo C, Seidenari S, Avramidis M, Menzies SW. In vivo reflectance confocal microscopy enhances secondary evaluation of melanocytic lesions. J Invest Dermotol. 2009 Jan;129(1):131-8. 

3. Menzies SW, Emery J, Staples M, McAvoy B, Avramidis M et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. British J Dermotol. 2009 Dec;161(6):1270-1278.

4. Arevalo A, Altamura D, Avramidis M, Blum A, Menzies SW. The significance of eccentric and hyperpigmentation, multifocal hyper-hypopigmentation and the multicomponent pattern in melanocytic lesions lacking specific dermoscopy features of melanoma. Arch Dermotol. 2008 Nov;144(11):1440-4.

5. Menzies SW, Kreusch J, Byth K, Avramidis M et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermotol. 2008 Sep 144(9):1120-7.

6. Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermotol. 2008 Apr;144(4):502-6.

7.  Pellacani G, Guitera P, Longo C, Avramidis M, Seidenari S, Menzies S. The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions. J Invest Dermotol. 2007 Dec;127(12):2759-65.  

8. Blum A, Ingvar C, Avramidis M, von Kannen A, Menzies SW, Olsson H, et al. Time to diagnosis of melanoma: same trend in different continents. J Cutan Med Surg. 2007 Jul-Aug;11(4):137-44. 

9. Kittler H, Guitera P, Riedl E, Avramidis M, Teban L, Fiebiger M, et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging.  Arch Dermotol. 2006 Sep;142(9):1113-9.

10. Menzies SW, Bischoff L, Talbot H, Gutenev A, Avramidis M, Wong L et al. The performance of SolarScan - an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma. Arch Dermotol 2005;141:1388-96

11. Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH. Short-term digital surface microscopy monitoring of atypical or changing melanocytic lesions. Arch Dermotol. 2001;137:1583-89